Publications
Found 23 results
Filters: Author is Conrath, Katja [Clear All Filters]
"Correction to Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2- a]pyridine Series of Autotaxin Inhibitors.",
J Med Chem, vol. 61, issue 9, pp. 4270, 2018 May 10.
"Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.",
J Med Chem, vol. 60, issue 17, pp. 7371-7392, 2017 Sep 14.
"A bacterial-two-hybrid selection system for one-step isolation of intracellularly functional Nanobodies.",
Arch Biochem Biophys, vol. 526, issue 2, pp. 114-23, 2012 Oct 15.
"Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.",
J Biol Chem, vol. 287, issue 3, pp. 1970-9, 2012 Jan 13.
"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.",
PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
"Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.",
Protein Sci, vol. 18, issue 3, pp. 619-28, 2009 Mar.
"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.",
J Biol Chem, vol. 284, issue 5, pp. 3273-84, 2009 Jan 30.
"Substrate-dependent modulation of enzyme activity by allosteric effector antibodies.",
Biochim Biophys Acta, vol. 1794, issue 8, pp. 1259-68, 2009 Aug.
"Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.",
J Mol Biol, vol. 377, issue 2, pp. 478-88, 2008 Mar 21.
"Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.",
J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
"VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.",
Mol Immunol, vol. 45, issue 14, pp. 3847-56, 2008 Aug.
"Antibody repertoire development in camelids.",
Dev Comp Immunol, vol. 30, issue 1-2, pp. 187-98, 2006.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.",
Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.",
Proc Natl Acad Sci U S A, vol. 103, issue 12, pp. 4586-91, 2006 Mar 21.
"Targeting and tracing antigens in live cells with fluorescent nanobodies.",
Nat Methods, vol. 3, issue 11, pp. 887-9, 2006 Nov.
"Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.",
J Mol Biol, vol. 350, issue 1, pp. 112-25, 2005 Jul 1.
"Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing.",
Anal Chem, vol. 77, issue 23, pp. 7547-55, 2005 Dec 1.
"Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.",
J Mol Biol, vol. 352, issue 3, pp. 597-607, 2005 Sep 23.
"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.",
J Biol Chem, vol. 279, issue 2, pp. 1256-61, 2004 Jan 9.
"Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.",
J Biol Chem, vol. 279, issue 50, pp. 51965-72, 2004 Dec 10.
"Efficient tumor targeting by single-domain antibody fragments of camels.",
Int J Cancer, vol. 98, issue 3, pp. 456-62, 2002 Mar 20.
"Single-domain antibody fragments with high conformational stability.",
Protein Sci, vol. 11, issue 3, pp. 500-15, 2002 Mar.